Here, we have focused our studies on deciphering the molecular role of NAA40 in colorectal cancer in which it was previously implicated [5] and we have established a new function for this enzyme in bridging epigenetic regulation and metabolism that is exploited by cancer cells to counteract anti-metabolite drug therapy. This evidence concerns the gene NAA40 and cancer.